Radiation oncologist; Artera clinical development team

Joined May 2018
14 Photos and videos
Tim Showalter retweeted
In this episode we chat w ⁦@othman CEO/cofounder⁩ ⁦@Color⁩ - give us a listen for a story of impact and inspiration for how health technology can improve care delivery podcasts.apple.com/us/podcas…
1
3
11
622
Tim Showalter retweeted
Congratulations to our friends and colleagues @arteraAI —their multimodal #ArtificialInteligence platform is revolutionary and applicable clinically. Bravo @arteraAI team! @TIME time.com/7094698/arterai-mul…
11
70
6,684
Tim Showalter retweeted
Dr. @TimShowalter1 from @arteraAI presented the data from prostate cancer and discussed possibilities of integrating tissue AI analysis in RCC. Very promising to have AI integration in RCC. #KCRS23 @OncoAlert
8
18
1,404
Can we take lessons learned from #prostatecancer into #kidneycancer? @TimShowalter1 says yes! @kidneycan @kidneycancer @kcCURE #KCRS23
2
6
33
2,685
Thank you for the invitation to share the potential impact we can make together for patients with #RCC #KCRS23 @arteraAI
Elegant talk on how #AI can guide development of biomarkers in #RCC by @TimShowalter1 #KCRS23 @OncoAlert @kidneycan
1
10
840
So excited to take on this exciting role with a tremendous team of new friends and some old colleagues! @NGThaker_XRT @dougfloramd @scottpenberthy
6 Jul 2023
ArteraAI is proud to announce that our own Tim Showalter MD, MPh, is part of the groundbreaking new academic journal - the only peer-reviewed research journal dedicated to the advancement of #AI applications in clinical & precision #oncology: bit.ly/3PuAjIk
3
4
27
4,130
Amazing work with direct clinical impact! Congrats to @DrSpratticus @NRGonc and the team at @arteraAI
This report used data derived and validated from completed randomized phase III trials to demonstrate that an AI-based predictive model could identify pts with predominately intermediate-risk #ProstateCancer who are likely to benefit from short-term androgen deprivation therapy.
3
10
2,936
Tim Showalter retweeted
26 Jun 2023
Are you passionate about #artificialintelligence and innovation in medical care? Join our team! Are you looking to make a difference with your career? #ArteraAI is seeking a #ClinicalResearch Associate. ➡️ Get full job details and apply here today: bit.ly/3PhrDVr
2
2
368
So much fun getting to be a shark for this! Exciting to see the potential impact of AI in brachytherapy. Congratulations to all three of the presenters for compelling proposals and pitches.
24 Jun 2023
Shark tank at ABS#2023 presentation on Chat GPT for brachy education ⁦@TimShowalter1⁩ ⁦@PranshuMohindra
2
19
1,598
Tim Showalter retweeted
24 Jun 2023
Shark tank at ABS#2023 presentation on Chat GPT for brachy education ⁦@TimShowalter1⁩ ⁦@PranshuMohindra
1
1
19
5,065
Congrats to Kara and the UVA team on completing the trial! Very excited to see the great results
@romano_kara found BrachyGel packing is preferred by brachytherapists & patients with no difference in dose to the cervix or OAR! #ABSBrachy23
1
1
14
1,536
Tim Showalter retweeted
8 Mar 2023
Did you catch Tim Showalter's presentation at #BiomarkersSeries23? 🇬🇧 Members of the Artera team met with attendees to discuss how the #ArteraAI #ProstateTest can help identify patients who will benefit from therapy intensification. ➡️ Learn more: artera.ai/our-test/
1
6
554
Tim Showalter retweeted
22 Feb 2023
What if there was a way to identify the patients who would benefit from therapy intensification? With #ArteraAI, there is. 💙 ➡️ Learn more about The ArteraAI #ProstateTest: artera.ai/our-test

2
5
706
Tim Showalter retweeted
21 Feb 2023
The Artera team is heading to #BiomarkersSeries23 2/27-2/28 in Manchester. 🇬🇧 Don't miss Dr. Tim Showalter's presentation "Pathology-Based Deep Learning Tools to Personalize Treatment Decisions: #ArteraAI #ProstateTest Development & Validation" on 2/27! bit.ly/3XEatCb

2
5
489
Tim Showalter retweeted
🏎️ FORMULA 509 @DrPaulNguyen #GU23 #pcsm @OncoAlert Salvage RT (med dose 68.4 Gy, 26% nodes tx) w 6 mos ADT ±intensification w AAP/Apa Overall PFS HR 0.71 p=.06 However pre-specified subgrp PSA>0.5 PFS HR 0.5, P=.03; MFS HR 0.32 p=.02 👉 potential alt to longer ADT in this pop
1
11
19
5,291
Tim Showalter retweeted
16 Feb 2023
#ArteraAI is at #GU23! Don't miss today's presentation with @DrSpratticus, as he shares results from six phase III randomized trials and how the use of MMAI prognostic biomarkers may improve the ability to assess risk in patients with #prostatecancer.⚕️ #ASCOGU
3
18
3,806
Tim Showalter retweeted
Thrilled to see a great turnout for the amazing IBC update from the incomparable @FilipaLynce @IBC_DanaFarber highlighting progress in biology, partnership with @SusanGKomen @MDAndersonNews for diagnosis tools and efforts to move good M1 tx to the M0 IBC setting! #SABCS2022
3
9
45
Tim Showalter retweeted
29 Oct 2022
More science highlights from ASTRO on UroToday! #ASTRO22 #ASTRO2022 #AI #ArteraAI urotoday.com/conference-high… via @urotoday

2
9